synced 3 MIN AGO
01 Record

CVE-2021-43935

ICSMA-21-343-01 Hillrom Welch Allyn Cardio Products

HighPUBLISHEDCNA: icscert
CNA base score8.1 CVSS v3.xCVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H

02 Description

ICSMA-21-343-01 Hillrom Welch Allyn Cardio Products

03 Exploitation and scoring

Exploitation
Not assessed. CISA has not published an exploitation assessment for this record, and it is not in the KEV catalog. That is an absence of assessment, not a finding of no risk.
SSVC decision
Not assessed by CISA
EPSS probability
1.14% probability of exploitation activity in the next 30 days.
EPSS percentile
Equal to or higher than the score of 66.2% of scored records. A rank, not a probability.
NVD base score
9.8 (CVSS v3.x), scored by the NVD independently of the CNA.
NVD CVSS vector
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
NVD analysis status
Modified. NVD last modified this record on 2026-06-17.
Red Hat severity
No Red Hat rating. Red Hat rates the CVEs that affect its products.

Exploit-prediction scores from FIRST. Independent scoring and analysis status from the NVD. Vendor severity from Red Hat. Exploitation assessment and catalog membership from CISA.

04 Metadata

Published
2021-12-15 18:05Z4 YR AGO
Last updated
2024-09-16 23:11Z2 YR AGO
Reserved
2021-11-16
Assigning CNA
icscert
Record state
PUBLISHED
Severity
High (CVSS 8.1)
CNA CVSS vector
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H
Weaknesses
  • CWE-288Authentication Bypass Using an Alternate Path or ChannelBase
  • CWE-287Improper AuthenticationClass
Data version
5.1
Document digest
6e592bd8450aea28b1df40c5b9bc9f46638da2b55d71818cbd4071479ba76a7c

05 Affected products

VendorProductVersionsPlatforms
HillromWelch Allyn Vision Express6.1.0 to 6.4.0—
HillromWelch Allyn Connex Cardio1.0.0 to 1.1.1—

06 References

07 Remediation

Hillrom recommends users upgrade to the latest product versions when updated products are available. Information on how to update these products to their new versions can be found on the Hillrom disclosure page.